The ACS Green Chemistry Institute Pharmaceutical Roundtable (GCIPR) estimates that solvents account for 80-90% of waste streams and 75-80% of the life cycle impact in pharmaceutical manufacturing. While sustainability efforts often focus on late-stage clinical and manufacturing processes, much less attention has been paid to solvent consumption during early drug discovery and how these choices influence downstream environmental impact.